Compounds which modulate the CB2 receptor

US8546563B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Angela Berry · Gaylordsville, US
• Doris Riether · Biberach an der Riß, DE
• Renee M. Zindell · New Milford, US
• Nigel James Blumire · Biggenden, AU

Key dates

• Filing date: Oct 30, 2008
• Grant date: Oct 1, 2013
• Expiry date: May 24, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.